Anemia And Other Blood Disorder Drugs Global Market Report 2022 – Yahoo Finance

Major players in the anemia and other blood disorder drugs market are Amgen Inc. , GlaxoSmithKline plc, Akebia Therapeutics, Bayer AG, Pfizer Inc. , Regen biopharma, Hoffmann-La Roche Ltd. , Merck Sharp & Dohme Corp.
New York, March 16, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report "Anemia And Other Blood Disorder Drugs Global Market Report 2022" – https://www.reportlinker.com/p06245020/?utm_source=GNW
, Novartis AG and Janssen Pharmaceutical.

The global anemia and other blood disorder drugs market is expected to grow from $10.29 billion in 2021 to $11.10 billion in 2022 at a compound annual growth rate (CAGR) of 7.8%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $14.32 billion in 2026 at a CAGR of 6.6%.

The anemia and other blood disorder drugs market consists of sales of anemia and other blood disorder drugs and related services.Anemia and other blood disorder drugs that are used to stimulate red blood cell production or hemoglobin in the human body include Erythropoietin (Epoetin alpha), Ferrous Sulfate, Iron Dextran, Deferoxamine, Immunosuppressant, Bone marrow stimulants, Corticosteroids, Aminoxin, Hespan, Hextend, and Pyridoxine.

The market also comprises of sales of drugs that are responsible for curing other blood disorders, including inherited orphan blood disorder.

The main types of anemia and other blood disorder drugs are iron deficiency anemia, chronic kidney disease anemia, sickle cell anemia and aplastic anemia.Iron deficiency anaemia is a common kind of anaemia in which the blood does not contain enough healthy red blood cells.

The oxygen-carrying red blood cells transport oxygen to the body’s cells.The different types of anemia include microcytic (Low MCV), normocytic (Normal MCV), macrocytic (High MCV) and involves various routes of administration such as oral, injectable.

It is distributed through hospitals pharmacy, online pharmacy, pharmacy.

North America is the largest region in the anemia and other blood disorder drugs market in 2021.Middle East is expected to be the fastest growing region in the forecast period.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The increasing prevalence of anemia among the global population acts as a strong driving factor for the market.Unhealthy lifestyles, changing dietary habits and increased stress levels increased the cases of anemia worldwide.

For instance, anemia was found to be the most frequent disease in the elderly population (> 65 years of age), reaching a prevalence rate of around 17%. the World Bank reported that anemia is the 8th leading cause of disease among women and the young population. Growth in the prevalence rate of anemia drives the market.

There has been an increase in the use of biologics for treating anemia and other blood disorders.Biologics are composed of protein, sugar, nucleic acids, or a combination of these substances or might be derived from living organisms like humans, animals, or microorganisms or that may contain components of living organisms.

The growth in the use of biologics over the drugs restricts the market resulting in the decline of the number of drugs being used for the treatment of anemia & other blood disorders.For example, Hospira, a medical device and pharmaceutical company, submitted its first biologics license application to FDA for the approval of a drug that treats anemia.

Moreover, the FDA approved the first Epoetin Alfa biosimilar for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection. The increase in the use of biologics will hamper the growth of the market.

Companies in the anemia and other blood disorder drugs market are collaborating with other companies to develop and commercialize a specific kind of drug by sharing the knowledge, technology, and cost.Such collaborations are also helpful to the companies in case of expiring licenses and stringent regulatory environment.

For example, in 2020, Akebia Therapeutics announced a collaboration with Tobacco Inc to treat adult patients with iron deficiency anemia. Another such example is, Akebia Therapeutics Inc. and Otsuka Pharmaceutical Co. Ltd. entered into an agreement to manufacture and commercialize Vadadustat, an oral HIF stabilizer, used for the treatment of anemia.

The anemia and other blood disorder drugs market is governed by several regulatory bodies that regulate their functioning by carrying out quality checks for that drug before it can be launched in the market. For instance, the U.S. Food & Drug Administration (FDA) requires every pharmaceutical company to get their drugs examined by the concerned authority. FDA sorts to a Risk Evaluation and Mitigation Strategy (REMS) for determining the safety and quality standards of the drug and grants approvals only if the standards are up to the mark.

In 2019, AMAG Pharmaceutical, an American pharmaceutical company agreed to acquire Perosphere for $415 million.The acquisition would result in expanding AMAG’s pipeline and enhance its presence in the Hematology drugs market with the help of Perosphere’s next-generation Anticoagulant reversal agent called Ciraparantag.

Perosphere is a specialty pharmaceutical company focusing on rescue drug medications. The Company was established in 2011 and is headquartered in Danbury, Connecticut, USA.

The countries covered in the anemia and other blood disorder drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Read the full report: https://www.reportlinker.com/p06245020/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Shares of Incannex Healthcare (NASDAQ: IXHL) were crashing 58.4% lower as of 3:52 p.m. ET on Wednesday. The huge decline came after the Australian drugmaker announced earlier today the issuance of 1.85 million shares related to the exercise of unlisted stock options. The addition of 1.85 million shares makes up less than 4% of Incannex Healthcare's outstanding shares.
Shares of Biogen Inc. gained 4.3% in premarket trading on Wednesday after the company announced new data for its Alzheimer's disease drug demonstrating reductions in amyloid beta plaques for 132 weeks and plasma p-tau181 for 128 weeks. The company also said in a news release that the clinical-trial data show that patients with lower plasma p-tau181 levels had less clinical decline. Adoption of Aduhelm has been low since it was approved in June. The drug generated $3 million in the six months of
Patients who received Biogen's Alzheimer's drug for over two years showed slower cognitive decline — leading Biogen stock to tick higher.
"I always felt like I had something to prove."
Apellis said Wednesday it plans to ask the FDA to approve its eye-disease treatment in the second quarter, and APLS stock surged.
When most companies spotlight record revenue growth, that means they’ve sold more product than ever before. But for pharmaceutical companies, that isn’t necessarily the case.
Vladimir Putin’s mental state is “normal”, the Kremlin insisted on Wednesday, amid rumours that the Russian president may be suffering from an illness or even an addiction to steroids.
Pfizer and its partner BioNTech asked U.S. regulators Tuesday to authorize an additional booster dose of their COVID-19 vaccine for seniors, saying data from Israel suggests older adults would benefit. Currently the U.S. urges two primary shots followed months later by a booster dose for everyone age 12 and older. The Food and Drug Administration and the Centers for Disease Control would have to approve the request.
Because, unfortunately, nature does not cure disease, even though the words of French philosopher and historian Voltaire would have you believe otherwise: "The art of medicine consists of amusing the patient while nature cures the disease," Voltaire had once famously said. TheStreet has compiled a list of some of the most expensive drug treatments in the world that cure diseases ranging from progeria, when infants start to look elderly to spinal muscular atrophy, neuroblastoma and a rare blood disorder. Swiss pharmaceutical giant Novartis apparently sells the most expensive drug in the world that costs $2.1 million.
Hailey Bieber confirmed weekend reports that on Thursday, she was briefly hospitalized but has fully recovered. Multiple outlets have reports on how the couple is doing in the aftermath.
Health insurers that sell private Medicare plans collected $12 billion more caring for seniors in 2020 than it would have cost in traditional Medicare, according to a report from the Medicare Payment Advisory Commission.It shows the need for major payment reforms, according to the report.Get market news worthy of your time with Axios Markets. Subscribe for free.Why it matters: Overpaying the Medicare Advantage plans as their enrollment continues to grow threatens Medicare's long-term finances.De
The disinfectant is commonly used to clean fish tanks
In a world where messages about body image and beauty standards can be overwhelming, how to we raise kids who love their bodies just the way they are? Yahoo Life asked body-positive influencer moms to share their tips.
As new research suggests folate deficiency is linked to dementia and premature death, dietitians explain how to get the essential vitamin.
Just as mandates end and more people are taking off their masks, another COVID variant is spreading, causing cases to rise around the world.
SEOUL (Reuters) -South Korea recorded a record 621,328 new daily COVID-19 cases and a daily record 429 deaths, authorities said on Thursday, as the country which once took an aggressive anti-pandemic approach is set to end COVID restrictions. The Korea Disease Control and Prevention Agency said the highly infectious Omicron variant was driving the record wave of infections and while a public survey revealed many expected to catch the virus, few feared serious health consequences. On Wednesday the government said it expected the wave to top out with daily cases in the mid-400,000.
‘I’m not sure people appreciate quite how bad the Covid situation is in Hong Kong, nor what might be around the corner’
‘Finally another mom does this,’ one respondent writes in the comments
STORY: In Kharkiv, Ukraine’s second largest city which has been under Russian attack for weeks, an impossible dilemma is unfolding for Pavlo Nartov, the director of the regional infectious diseases hospital…to either move critically ill COVID patients to the safety of the bomb shelter in the hospital’s basement or leave them connected to the oxygen supply in their rooms."Employees and patients able to walk come down here. But, you know, most of our patients are on oxygen supply all the time. They can’t be cut off oxygen…The ones in critical condition remain in their rooms. If we bring them down here they will simply die."The regional emergency service said on Wednesday that at least 500 residents of the city have been killed since the start of Russia’s invasion on February 24th.A Kharkiv official said on Tuesday that more than 600 buildings have been destroyed, including schools, nurseries, and hospitals.Nartov is relieved his hospital has been spared for now, but staff are preparing for the worst, having stocked up on medical supplies before the invasion began."The situation is difficult and tense. As you can see, sick people, covered windows, bombardment going on from morning till night. Thanks god, our territory, our hospital has not yet been hit."The staff are now learning how to use a gas mask, in case of a chemical attack.Natalya Titarenko, who works at the hospital, said the building she lives in and the building of her sister had both recently been hit by Russian shells."Suddenly we heard a sharp noise. My husband said 'they hit the house', there was a cloud of dust in our apartment and our neighbors started screaming. I opened the door, it was not damaged, I opened it and I saw in the yard a smoke curtain, dust, glass smashed everywhere…”Russia says it does not target civilians, describing its actions as a "special operation" to demilitarize and "de-Nazify" Ukraine, a move the country and its allies call a baseless pretext for war.
The case that has led to multiple days of protests in Boise.

source

Add a Comment

Your email address will not be published. Required fields are marked *